Recruiting for Acute Myocardial Infarction Cell Therapy Trials: Challenges and Best Practices for the CCTRN.
作者信息
Olson Rachel E, Vojvodic Rachel W, Bettencourt Judy, Handberg Eileen M, Szymanski Elizabeth, Smith Deirdre, LaRock Jody, Sharma Shreela V, Taylor Doris A, Henry Timothy D
机构信息
Minneapolis Heart Institute Foundation. She can be reached at
University of Texas School of Public Health-Houston, and a project manager with the Cardiovascular Cell Therapy Research Network (CCTRN). She can be reached at
出版信息
Clin Res (Alex). 2014 Aug;28(4):71-77.
Abstract
摘要
相似文献
1
Recruiting for Acute Myocardial Infarction Cell Therapy Trials: Challenges and Best Practices for the CCTRN.急性心肌梗死细胞治疗试验的招募：加拿大临床试验研究网络（CCTRN）面临的挑战与最佳实践
Clin Res (Alex). 2014 Aug;28(4):71-77.
2
Bone good to the heart: bone marrow cell characteristics and cardiac repair after STEMI in the CCTRN TIME cohort.骨骼对心脏有益：CCTRN TIME队列中ST段抬高型心肌梗死后骨髓细胞特征与心脏修复
Circ Res. 2015 Jan 2;116(1):16-8. doi: 10.1161/CIRCRESAHA.114.305502.
3
Stem cell therapy for the treatment of myocardial infarction.干细胞治疗心肌梗死。
Curr Pharm Des. 2011 Oct;17(30):3328-40. doi: 10.2174/138161211797904208.
4
Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).ST段抬高型心肌梗死的治疗差异及再灌注错失机会：全球急性冠状动脉事件注册研究（GRACE）的结果
Lancet. 2002 Feb 2;359(9304):373-7. doi: 10.1016/S0140-6736(02)07595-5.
5
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.糖蛋白IIb/IIIa抑制剂疗法在急性ST段抬高型心肌梗死中的应用：当前实践与未来趋势。
Am J Cardiol. 2000 Apr 27;85(8A):32C-8C. doi: 10.1016/s0002-9149(00)00877-8.
6
Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).急性心肌梗死中他汀类药物的处方模式：法国急性ST段抬高或非ST段抬高型心肌梗死注册研究（FAST-MI）
Atherosclerosis. 2009 Jun;204(2):491-6. doi: 10.1016/j.atherosclerosis.2008.09.031. Epub 2008 Oct 8.
7
Streptokinase for the treatment of acute myocardial infarction: a brief review of randomized trials.链激酶治疗急性心肌梗死：随机试验简要综述
J Am Coll Cardiol. 1987 Nov;10(5 Suppl B):28B-32B. doi: 10.1016/s0735-1097(87)80425-4.
8
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.设计和/或实施随机试验的医生与从事常规临床实践的医生在急性心肌梗死药物治疗使用方面的趋势：MILIS-TIMI研究经验。梗死面积限制多中心调查。心肌梗死溶栓治疗。
Am Heart J. 1999 Jan;137(1):79-92. doi: 10.1016/s0002-8703(99)70462-x.
9
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).丹麦关于急性心肌梗死中溶栓治疗与急性冠状动脉血管成形术的多中心随机研究：丹麦急性心肌梗死试验-2（DANAMI-2）的原理与设计
Am Heart J. 2003 Aug;146(2):234-41. doi: 10.1016/S0002-8703(03)00316-8.
10
Oxygen therapy for acute myocardial infarction: A systematic review and meta-analysis.急性心肌梗死的氧疗：系统评价和荟萃分析。
Int J Nurs Stud. 2017 Sep;74:8-14. doi: 10.1016/j.ijnurstu.2017.04.005. Epub 2017 Apr 17.
引用本文的文献
1
Sex-Based Differences in Autologous Cell Therapy Trials in Patients With Acute Myocardial Infarction: Subanalysis of the ACCRUE Database.急性心肌梗死患者自体细胞治疗试验中的性别差异：ACCRUE数据库的亚分析
Front Cardiovasc Med. 2021 May 26;8:664277. doi: 10.3389/fcvm.2021.664277. eCollection 2021.
本文引用的文献
1
Clinical trials in cardiology: pinnacle or inflection point?心脏病学临床试验：巅峰还是转折点？
Circ Res. 2014 Jan 3;114(1):28-31. doi: 10.1161/CIRCRESAHA.113.302851.
2
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.骨髓单个核细胞应用时间和方式对急性心肌梗死后左心室功能的影响：TIME 随机试验。
JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.
3
Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.美国国立心肺血液研究所对心血管细胞治疗研究的支持。
Circ Res. 2012 Jun 8;110(12):1549-55. doi: 10.1161/RES.0b013e31825ec2a3.
4
Minority recruitment into clinical trials: experimental findings and practical implications.少数民族参与临床试验：实验结果与实际意义。
Contemp Clin Trials. 2012 Jul;33(4):620-3. doi: 10.1016/j.cct.2012.03.003. Epub 2012 Mar 16.
5
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.急性心肌梗死后 2 至 3 周经冠状动脉内自体骨髓单个核细胞移植对左心室功能的影响：晚期时间随机试验。
JAMA. 2011 Nov 16;306(19):2110-9. doi: 10.1001/jama.2011.1670. Epub 2011 Nov 14.
6
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experience.细胞治疗和卫星中心：心血管细胞治疗研究网络的经验。
Contemp Clin Trials. 2011 Nov;32(6):841-7. doi: 10.1016/j.cct.2011.07.001. Epub 2011 Jul 8.
7
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.晚期心肌梗死时间试验：一项II期、随机、双盲、安慰剂对照的先导试验，评估急性心肌梗死后2至3周给予骨髓单个核细胞的安全性和效果。
Tex Heart Inst J. 2010;37(4):412-20.
8
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.骨髓单个核干细胞输注治疗 ST 段抬高型心肌梗死患者的 1 期随机、双盲、安慰剂对照临床试验结果。
Am Heart J. 2010 Sep;160(3):428-34. doi: 10.1016/j.ahj.2010.06.009.
9
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.多中心细胞处理在心血管再生医学中的应用：心血管细胞治疗研究网络（CCTRN）的经验。
Cytotherapy. 2010 Sep;12(5):684-91. doi: 10.3109/14653249.2010.487900.
10
Clinical trials: the challenge of recruitment and retention of participants.临床试验：参与者招募和保留的挑战。
J Clin Nurs. 2010 Jan;19(1-2):227-33. doi: 10.1111/j.1365-2702.2009.03041.x.
Zotero 插件